Porcine pancreatic kallikrein is a serine protease whose enzymatic activity centers on the selective cleavage of specific peptide bonds within kininogen, a glycoprotein precursor of bradykinin. The enzyme primarily hydrolyzes peptide bonds at the carboxyl side of arginine (Arg–X) residues, where "X" can be any amino acid, though certain neighboring residues influence substrate specificity.
- Catalytic process
The catalytic mechanism of porcine pancreatic kallikrein involves a highly conserved catalytic triad—Histidine (His), Aspartate (Asp), and Serine (Ser)—which is characteristic of the trypsin-like subclass of serine proteases. These three amino acid residues work synergistically to cleave peptide bonds. His acts as a base to deprotonate the hydroxyl group of the serine residue. Ser, now nucleophilic, attacks the carbonyl carbon of the target peptide bond within kininogen. Asp stabilizes the positive charge developed on histidine during catalysis. This results in the formation of a tetrahedral intermediate, followed by bond cleavage and release of the bradykinin peptide, along with regeneration of the active site.
- Activation mechanism
Kallikrein is synthesized as an inactive precursor (zymogen) called prokallikrein. It requires proteolytic activation to become enzymatically active:
- Trypsin, a serine protease found in the pancreas, can cleave a specific activation peptide in prokallikrein to convert it into active kallikrein.
- Alternatively, kallikrein may undergo autolytic cleavage, where an already active kallikrein molecule activates additional prokallikrein molecules—creating a positive feedback loop.
This activation mechanism ensures that kallikrein remains dormant until needed, preventing unintended proteolytic activity in the pancreas or bloodstream.
- Substrate specificity and product formation
Once activated, kallikrein targets low- and high-molecular-weight kininogens, cleaving specific Arg–Ser or Arg–Met bonds to release bradykinin (a 9-amino-acid peptide). This process is central to initiating the kinin cascade, leading to downstream effects such as increased vasodilation, stimulation of inflammatory pathways, activation of pain receptors, and facilitation of immune cell migration.